tetano
Editor, Senior Moderator
iScience
. 2021 Feb 5;24(3):102148.
doi: 10.1016/j.isci.2021.102148. eCollection 2021 Mar 19.
A computational framework of host-based drug repositioning for broad-spectrum antivirals against RNA viruses
Zexu Li[SUP] 1 2 [/SUP], Yingjia Yao[SUP] 1 2 [/SUP], Xiaolong Cheng[SUP] 3 4 [/SUP], Qing Chen[SUP] 3 4 [/SUP], Wenchang Zhao[SUP] 1 2 [/SUP], Shixin Ma[SUP] 1 2 [/SUP], Zihan Li[SUP] 1 2 [/SUP], Hu Zhou[SUP] 5 6 [/SUP], Wei Li[SUP] 3 4 [/SUP], Teng Fei[SUP] 1 2 [/SUP]
Affiliations
Abstract
RNA viruses are responsible for many zoonotic diseases that post great challenges for public health. Effective therapeutics against these viral infections remain limited. Here, we deployed a computational framework for host-based drug repositioning to predict potential antiviral drugs from 2,352 approved drugs and 1,062 natural compounds embedded in herbs of traditional Chinese medicine. By systematically interrogating public genetic screening data, we comprehensively cataloged host dependency genes (HDGs) that are indispensable for successful viral infection corresponding to 10 families and 29 species of RNA viruses. We then utilized these HDGs as potential drug targets and interrogated extensive drug-target interactions through database retrieval, literature mining, and de novo prediction using artificial intelligence-based algorithms. Repurposed drugs or natural compounds were proposed against many viral pathogens such as coronaviruses including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), flaviviruses, and influenza viruses. This study helps to prioritize promising drug candidates for in-depth evaluation against these virus-related diseases.
Keywords: Bioinformatics; Molecular Biology; Pharmacoinformatics.
. 2021 Feb 5;24(3):102148.
doi: 10.1016/j.isci.2021.102148. eCollection 2021 Mar 19.
A computational framework of host-based drug repositioning for broad-spectrum antivirals against RNA viruses
Zexu Li[SUP] 1 2 [/SUP], Yingjia Yao[SUP] 1 2 [/SUP], Xiaolong Cheng[SUP] 3 4 [/SUP], Qing Chen[SUP] 3 4 [/SUP], Wenchang Zhao[SUP] 1 2 [/SUP], Shixin Ma[SUP] 1 2 [/SUP], Zihan Li[SUP] 1 2 [/SUP], Hu Zhou[SUP] 5 6 [/SUP], Wei Li[SUP] 3 4 [/SUP], Teng Fei[SUP] 1 2 [/SUP]
Affiliations
- PMID: 33665567
- PMCID: PMC7900436
- DOI: 10.1016/j.isci.2021.102148
Abstract
RNA viruses are responsible for many zoonotic diseases that post great challenges for public health. Effective therapeutics against these viral infections remain limited. Here, we deployed a computational framework for host-based drug repositioning to predict potential antiviral drugs from 2,352 approved drugs and 1,062 natural compounds embedded in herbs of traditional Chinese medicine. By systematically interrogating public genetic screening data, we comprehensively cataloged host dependency genes (HDGs) that are indispensable for successful viral infection corresponding to 10 families and 29 species of RNA viruses. We then utilized these HDGs as potential drug targets and interrogated extensive drug-target interactions through database retrieval, literature mining, and de novo prediction using artificial intelligence-based algorithms. Repurposed drugs or natural compounds were proposed against many viral pathogens such as coronaviruses including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), flaviviruses, and influenza viruses. This study helps to prioritize promising drug candidates for in-depth evaluation against these virus-related diseases.
Keywords: Bioinformatics; Molecular Biology; Pharmacoinformatics.